PharmX TechnologiesASX:PHX 40 OCF Margin % is 6.10% as of Dec. 2025, which is 54% below its 10-year median of 13.30. GuruFocus rates ASX:PHX with a GF Score™ of 40/100 and a GF Value™ of A$0.07 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 668 Healthcare Providers & Services companies, PharmX Technologies ranks better than 64.37% on this metric.
The historical rank and industry rank for PharmX Technologies's OCF Margin % or its related term are showing as below:
ASX:PHX'
s OCF Margin % Range Over the Past 10 Years
Min: -111.11 Med: 13.3 Max: 181.85
Current: 13.47
During the past 13 years, the highest OCF Margin % of PharmX Technologies was 181.85%. The lowest was -111.11%. And the median was 13.30%.
ASX:PHX's OCF Margin % is ranked better than 64.37% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 8.33
vs ASX:PHX: 13.47
PharmX Technologies OCF Margin % Related Terms
PharmX Technologies OCF Margin % Historical Data
* Premium members only.
The historical data trend for PharmX Technologies's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:PHX vs VEEV, BTSG, TEM: OCF Margin % Comparison
For the Health Information Services subindustry, PharmX Technologies's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PharmX Technologies OCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PharmX Technologies's OCF Margin % distribution charts can be found below:
* The bar in red indicates where PharmX Technologies's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PharmX Technologies (ASX:PHX) has a OCF Margin % of 6.10% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on PharmX Technologies and its competitors. This is 54% below median its historical median of 13.30. According to the industry distribution chart, PharmX Technologies ranks #238 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 35.6%.
Is PharmX Technologies' OCF Margin % too high?
PharmX Technologies' current OCF Margin % of 6.10% is 54% below median its 10-year median of 13.30. The Healthcare Providers & Services industry median OCF Margin % is 8.33. PharmX Technologies' value of 6.10% is 26.8% below this industry median. Based on the distribution chart, PharmX Technologies ranks #238 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, PharmX Technologies has a GF Score™ of 40/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PharmX Technologies' OCF Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, PharmX Technologies ranks #238 out of 668 companies for OCF Margin %. This puts PharmX Technologies in the upper half of its industry. The industry median OCF Margin % is 8.33. PharmX Technologies' value of 6.10% is 26.8% below this benchmark. While the company's 10-year median is 13.30 vs. the industry median of 8.33, PharmX Technologies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Healthcare Providers & Services company?
The median OCF Margin % among Healthcare Providers & Services companies is 8.33, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PharmX Technologies's current OCF Margin % of 6.10% is 26.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on PharmX Technologies and its competitors. For the Healthcare Providers & Services industry, the median OCF Margin % is 8.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PharmX Technologies's current OCF Margin % is 6.10%, which is 54% below median its own 10-year median of 13.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmX Technologies stock overvalued right now?
Based on GuruFocus' analysis, PharmX Technologies (ASX:PHX) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.07, compared to a current price of A$0.13 — trading 85.7% above its estimated fair value. The current OCF Margin % is 6.10%, which is 54% below median its 10-year median of 13.30 and 26.8% below the Healthcare Providers & Services industry median of 8.33. PharmX Technologies' overall GF Score™ is 40/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For PharmX Technologies (ASX:PHX), the current OCF Margin % is 6.10% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PharmX Technologies (ASX:PHX) Overvalued in 2026?
Based on GuruFocus' analysis, PharmX Technologies stock appears to be overvalued.
The current stock price of A$0.13 is trading 85.7% above its estimated GF Value™ of A$0.07.
GuruFocus considers PharmX Technologies to be Significantly Overvalued.
Key valuation signals for ASX:PHX:
OCF Margin %: 6.10% (54% below median its 10-year median of 13.30)
GF Value™: A$0.07 vs. price of A$0.13 (85.7% above fair value)
Industry Position: 26.8% below the Healthcare Providers & Services median (#238 of 668)
No single metric tells the full story. See the ASX:PHX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PharmX Technologies Ltd is an Australia-based software and technology company. The company has a single segment which is Health Services. In Health services, the company develops and distributes business software for the pharmacy industry with particular emphasis on point-of-sale and pharmaceutical dispensing software, support services, and associated computer hardware. It derives a majority of its revenue from the Health services business.
40GF Score
Get the complete analysis for ASX:PHX
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:PHX has been successfully added to your 
